Decibel Therapeutics, Inc. Undistributed Earnings (Loss) Allocated to Participating Securities, Basic
Decibel Therapeutics, Inc. reported Undistributed Earnings (Loss) Allocated to Participating Securities, Basic of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-18.
Discontinued › Expense Statement › Operating Expenses
us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic · last filed 2022-03-18
- Decibel Therapeutics, Inc. undistributed earnings (loss) allocated to participating securities, basic for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- Decibel Therapeutics, Inc. undistributed earnings (loss) allocated to participating securities, basic for fiscal 2020 was $44.87M.
| Period end | Undistributed Earnings (Loss) Allocated to Participating Securities, Basic 12 month |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-18 |
| 2020-12-31 | $44.87M 10-K · filed 2022-03-18 |